7383-12-2 Usage
Uses
Used in Pharmaceutical Research:
(2-methoxy-5-methylphenyl)methanamine is used as an intermediate in organic synthesis for the development of new drugs, targeting various diseases due to its potential medicinal properties.
Used in Medicinal Applications:
(2-methoxy-5-methylphenyl)methanamine is used as a therapeutic agent for its demonstrated biological activities, such as anti-inflammatory and antitumor effects, contributing to the treatment of different medical conditions.
Used in Organic Synthesis:
(2-methoxy-5-methylphenyl)methanamine is used as a building block in the synthesis of complex organic molecules, facilitating the creation of novel compounds with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 7383-12-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,3,8 and 3 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 7383-12:
(6*7)+(5*3)+(4*8)+(3*3)+(2*1)+(1*2)=102
102 % 10 = 2
So 7383-12-2 is a valid CAS Registry Number.
7383-12-2Relevant academic research and scientific papers
PYRAZOLOPYRIDINE PYRAZOLOPYRIMIDINE AND RELATED COMPOUNDS
-
Paragraph 0386, (2015/11/25)
In one aspect this invention relates generally to compounds of Formula: and sub-formulas thereof, or a tautomer of each thereof, a pharmaceutically acceptable salt of each thereof, or a pharmaceutically acceptable solvate of each of the foregoing, where X1, L1, L3, and R3 are described herein.
DIAMINOPYRIMIDINECARBOXA MIDE DERIVATIVE
-
Page/Page column 21, (2008/06/13)
A compound which may be used for the prevention or treatment of respiratory diseases in which STAT 6 is concerned, particularly asthma, chronic obstructive pulmonary disease and the like is provided. A pyrimidine derivative or a salt thereof, which has an arylamino or arylethylamino group which may be substituted with a specified substituent, at the 2-position, amino group substituted with benzyl group or the like, at the 4-position, and carbamoyl group which may be substituted, at the 5-position, is provided.
